Analysts are reworking their price targets for Gladstone Commercial, keeping model fair value at $13.38 per share while bullish views cluster around a $12.50 to $14 range, tied to a 12 month forward ...
Ocugen’s updated fair value estimate has shifted from US$10.36 to US$11.57, putting recent analyst work into a slightly higher price target range. Analysts are tying this move to fresh research around ...